PhaseRx, Inc. (PZRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 410 WEST HARRISON STREET
SEATTLE, WA 98119
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2017
MRQ
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 15,500,000
Cash and cash equivalents 9,983,000
Short-term investments 5,496,000
Other undisclosed cash, cash equivalents, and short-term investments 21,000
Other undisclosed current assets 677,000
Total current assets: 16,177,000
Noncurrent Assets
Property, plant and equipment 271,000
Total noncurrent assets: 271,000
TOTAL ASSETS: 16,448,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,448,000
Interest and dividends payable 49,000
Accounts payable 515,000
Accrued liabilities 884,000
Debt 576,000
Total current liabilities: 2,024,000
Noncurrent Liabilities
Long-term debt and lease obligation 5,127,000
Long-term debt, excluding current maturities 5,127,000
Total noncurrent liabilities: 5,127,000
Total liabilities: 7,151,000
Equity
Equity, attributable to parent 9,297,000
Common stock 1,000
Additional paid in capital 78,773,000
Accumulated other comprehensive income 3,000
Accumulated deficit (69,480,000)
Total equity: 9,297,000
TOTAL LIABILITIES AND EQUITY: 16,448,000

Income Statement (P&L) (USD)

9/30/2017
TTM
12/31/2016
Operating expenses (18,330,000)
Operating loss: (18,330,000)
Nonoperating expense (1,807,000)
Interest and debt expense (2,058,000)
Loss from continuing operations: (22,195,000)
Loss before gain (loss) on sale of properties: (22,195,000)
Net loss: (22,195,000)
Other undisclosed net income attributable to parent 2,058,000
Net loss available to common stockholders, diluted: (20,137,000)

Comprehensive Income (USD)

9/30/2017
TTM
12/31/2016
Net loss: (22,195,000)
Comprehensive loss: (22,195,000)
Other undisclosed comprehensive income, net of tax, attributable to parent 2,061,000
Comprehensive loss, net of tax, attributable to parent: (20,134,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: